1Sadigh-Lindell B, Sylven C, Berghmd M, et al . Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study[J]. J Cardiovasc Pharmacol, 2003 ,42:757-763.
2Amnow WS. Silent [vii. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms[J].Geriatrics, 2003, 58 : 24-40.
3Stone P, Chairman B, Fonnan S, et al . Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot (ACIP) study) [J]. Am J Cardiol, 1997,80:1395-1401.
4Gibbons R, Balady G, Beasley J, et al . ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Conmtittee on Exercise Testing)[J] .J Am Coil Cardiol,1997,30:260-311.
5Opthof T, Colonel R, Vermeulen J T, et al . Dispersion of refractoriness in normal and ischemic canine ventricle: effects of synmpthetic stimulation[J]. Cardiovasc Res, 1993,27 : 1954.
6Chairman B, Stone P, Nauemd GL, et al . The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Impact of antiischemia therapy on 12-week test ECG and exercise test outcomes[J]. J Am Coil Cardiol,1995,26: 585-590.
7Pepine CJ, Cohn PF, Deedwania PC, et al . Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)[J]. Cirettlation,1994,90:762-768.
9Aengevaeren W, Uijen GJ, Jukema J, et al . Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study ( REGRKSS ) [ J ]. Circulation, 1997,96: 429-435.
10Cohn PF. Silent myocardial ischemia : clinical significance and relation to sudden cardiac death[J]. Chest, 1986,90:597-602.
